CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

Nippon India Pharma Fund(G)

very highequitypharma & health care
506.54 -3.16(-0.62%) NAV as on 12 Feb 2026
-0.35 % 1 M
7.07 % 1 Y
22.16 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.83

As on 31 Jan, 2026
age-icon Age :

21 yrs 8 m

Since 05 06 ,2004
exit_load Exit Load :

1%

aum AUM :

7,875.40 Crs

lock_in Lock-in :

1% on or before 1M, Nil after 1M

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

7.26

Min_Investment Min. Investment :

SIP 100 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Sailesh Raj Bhan

LATEST ASSET & PORTFOLIO ALLOCATION

as on Jan 31 ,2026
Others 1.03 %
Equity 98.97 %

TOP HOLDINGS

Sun Pharmaceutical Industries...12.67 %
Lupin Ltd.7.88 %
Divi's Laboratories Ltd.6.54 %
Dr. Reddy's Laboratories Ltd.6.06 %
Cipla Ltd.5.88 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs74.29
Hospital & Healthcare Services19.86
Retailing3.68
Business Support1.13
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-20252025-2026
NAV in Rs (as on 12-Feb-2026)290.14270.59428.87481.27506.54
Net Assets(Rs Crores) (as on 12-Feb-2026) 4931.89 4304.46 7125.28 8080.97 7875.40
Scheme Returns(%)(Absolute)14.83-6.8558.2410.946.85
B'mark Returns(%)(Absolute)NANANANANA
Category Rank43/7565/7617/9030/10275/115

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Nippon India Pharma Fund(G)Very HighEquity506.54-3.16(-0.62%)NAV As on 12 Feb, 202605-Jun-2004Inception Date7,875.40AUM In Cr.7.07%1Y22.16%3Y14.81%5Y19.82%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity38.35-0.18(-0.47%)NAV As on 12 Feb, 202613-Jul-2018Inception Date6,658.41AUM In Cr.6.20%1Y26.52%3Y16.74%5Y19.37%Since Inception
corporate OFFICE Jhaveri Securities301/302 Payal Tower-II,Opp. M. S. University, Sayajigunj, Vadodara 390020.
CALL US 91-265-6161200/7161200
EMAIL US info@jhaveritrade.com
SEBI Reg. No. NSE, BSE, MCX : INZ000199232 Membership No.: NSE:08232, BSE:3015, MCX:56465 SEBI Regn.No. of DP : IN-DP-195-2016 (NSDL DPID:IN301991) AMFI: ARN-A3524 CIN of JSL: U67120GJ1992PLC018194 | GST : 24AAACJ4727A2Z4
COMPLIANCE OFFICER OFFICE
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors
© CopyRights 2022, Jhaveri Securities All rights reserved.
Designed & Developed by Accord Fintech Pvt Ltd.